MedTrace Logo

Reduction of Foveal Sensitivity in Eyes With Diabetic Macular Edema

NCT01824862 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2013-07-11

No results posted yet for this study

Summary

Clinically significant macular edema (CSME) is a thickening of the macula associated with the risk of visual loss, which increases its centre is involved. Functional evaluation of the macula relies on best corrected visual acuity; however, neural dysfunction in diabetic eyes appears before retinal thickening and visual loss. Retinal sensitivity decreases in eyes with CSME, but it is unknown whether it differs between eyes with and without centre thickening.

Aim: To compare the reduction of foveal sensitivity in eyes with CSME, with and without centre thickening.

Conditions

Sponsors & Collaborators

  • Hospital Juarez de Mexico

    lead OTHER_GOV

Principal Investigators

  • VIRGILIO LIMA GOMEZ, PhD · Hospital Juarez de Mexico

  • Dulce M Razo Blanco Hernandez, MSc · Hospital Juárez de México

Eligibility

Min Age
30 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2013-06-30
Completion
2013-07-31

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01824862 on ClinicalTrials.gov